Publication: FGF23, Biomarker or Target?
Loading...
Identifiers
Date
2019-03-19
Authors
Rodelo-Haad, Cristian
Santamaria, Rafael
Muñoz-Castañeda, Juan R
Pendon-Ruiz de Mier, M Victoria
Martin-Malo, Alejandro
Rodriguez, Mariano
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Abstract
Fibroblast growth factor 23 (FGF23) plays a key role in the complex network between the bones and other organs. Initially, it was thought that FGF23 exclusively regulated phosphate and vitamin D metabolism; however, recent research has demonstrated that an excess of FGF23 has other effects that may be detrimental in some cases. The understanding of the signaling pathways through which FGF23 acts in different organs is crucial to develop strategies aiming to prevent the negative effects associated with high FGF23 levels. FGF23 has been described to have effects on the heart, promoting left ventricular hypertrophy (LVH); the liver, leading to production of inflammatory cytokines; the bones, inhibiting mineralization; and the bone marrow, by reducing the production of erythropoietin (EPO). The identification of FGF23 receptors will play a remarkable role in future research since its selective blockade might reduce the adverse effects of FGF23. Patients with chronic kidney disease (CKD) have very high levels of FGF23 and may be the population suffering from the most adverse FGF23-related effects. The general population, as well as kidney transplant recipients, may also be affected by high FGF23. Whether the association between FGF23 and clinical events is causal or casual remains controversial. The hypothesis that FGF23 could be considered a therapeutic target is gaining relevance and may become a promising field of investigation in the future.
Description
MeSH Terms
Animals
Biomarkers
Fibroblast growth factor-23
Fibroblast growth factors
Humans
Hyperparathyroidism, secondary
Biomarkers
Fibroblast growth factor-23
Fibroblast growth factors
Humans
Hyperparathyroidism, secondary
DeCS Terms
Animales
Biomarcadores
Factor-23 de crecimiento de fibroblastos
Factores de crecimiento de fibroblastos
Hiperparatiroidismo secundario
Biomarcadores
Factor-23 de crecimiento de fibroblastos
Factores de crecimiento de fibroblastos
Hiperparatiroidismo secundario
CIE Terms
Keywords
Calcium, Chronic kidney disease, Dialysis, Fibroblast growth factor 23 (FGF23), Parathyroid hormone, Phosphate
Citation
Rodelo-Haad C, Santamaria R, Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Martin-Malo A, Rodriguez M. FGF23, Biomarker or Target? Toxins (Basel). 2019 Mar 22;11(3):175